Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

103 results about "Contact lens care" patented technology

Phospholipid Compositions for Contact Lens Care and Preservation of Pharmaceutical Compositions

The use of certain synthetic phospholipids to preserve pharmaceutical compositions from microbial contamination is described. The synthetic phospholipids have unique molecular arrangements wherein a phosphate group is linked to a quaternary ammonium functionality via a substituted-propenyl group, and the quaternary ammonium functionality is further linked to at least one long hydrocarbon chain. Such molecular arrangements are what make the phospholipids of formula (I) highly water soluble, e.g., the length of the hydrocarbon chain assists to maintain solubility and efficacy of the molecules for the uses described herein. The synthetic phospholipids described herein have been found to be particularly useful as antimicrobial preservatives for ophthalmic, otic and nasal pharmaceutical compositions, especially ophthalmic compositions. These compounds may also be utilized to disinfect contact lenses. The invention is based in-part upon a finding that the antimicrobial activity of the synthetic phospholipids is affected by the ionic strength of the compositions in which the compounds are contained. The provision of compounds having limited ionic strengths is therefore preferred.
Owner:ALCON RES LTD

Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof

Ophthalmic composition including a carboxyl-modified fructan or a salt thereof. The ophthalmic composition can be used in an eye care product or a contact lens care product such as a contact lens packaging solution or contact lens disinfecting solution.
Owner:BAUSCH & LOMB INC

Contact lens nursing liquid or moisture retention eye drop containing polyethylene glycol hydrogenated castor oil

The invention discloses contact lens nursing liquid or moisture eye moistening liquid containing polyoxyethylene hydrogen castor oil. The contact lens nursing liquid is composed of the polyoxyethylene hydrogen castor oil, pH regulator, osmotic pressure regulator, metal complex, surface active agent, thickening agent, bactericide and water, and the contact lens lubricating moist liquid is composed of the polyoxyethylene hydrogen castor oil, the pH regulator, the osmotic pressure regulator, the metal complex, the thickening agent, preservative and water. The polyoxyethylene hydrogen castor oil selected by the invention has a plurality of branched chains and good lubricating performance; and the existence of the polyoxyethylene end enable the product to have good moist performance. The polyoxyethylene hydrogen castor oil is viscous liquid, is easily dissolved in water, has even solution performance, and does not have the condition that fine granules or macromolecules curl and enwind in aqueous solution because solid macromolecule raw materials can not completely dissolved to further cause the problem that eyes feel uncomfortable. The obtained product is achromatous and flavourless, and has good user reception, low production cost, and wide source of the main material of the castor oil.
Owner:GUANGZHOU BAOSHINING OPTICAL PROD

Lens care solutions comprising alkyldimonium hydroxypropyl alkylglucosides

A contact lens care solution comprising one or more alkyldimonium hydroxypropyl alkylglucosides of general formula I or general formula IIwherein R is a straight or branched C8-C24alkyl;A is —CH2CH(OH)CH2N+(CH3)2R1X−, wherein R1 is a C8-C24alkyl and X− is a common counteranion, n is an average value from 1 to 6 and m is an average value from 1 to 2. The solution is formulated to clean and disinfect contact lenses or the solution is formulated as a rewet eye drop for use with contact lenses.
Owner:BAUSCH & LOMB INC

Multi purpose contact lens care compositions including propylene glycol or glycerin

Multi-purpose solutions for contact lens care provide substantial lens wearer / user comfort and / or acceptability. Such solutions include an aqueous liquid medium; an antimicrobial component, preferably a biguanide polymer present in an amount of less than about 5 ppm; propylene glycol or glycerin in an amount sufficient to increase antimicrobial activity; a surfactant component, preferably a poly(oxyethylene)-poly(oxypropylene) block copolymer surfactant, in an effective amount; a phosphate buffer component in an effective amount; a viscosity inducing component, preferably selected from cellulosic derivatives, in an effective amount; and a tonicity component in an effective amount. Such solutions have substantial performance, comfort and acceptability benefits, which, ultimately, lead to ocular health advantages and avoidance of problems caused by contact lens wear.
Owner:ADVANCED MEDICAL OPTICS

Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease

ActiveUS20130102679A1Reduce generationSigns of redness of the eyeBiocideSenses disorderPapillary conjunctivitisConjunctival inflammation
The invention provides a use of panthenol or dexpanthenol in the prevention and / or treatment of contact lens papillary conjunctivitis in a subject. A contact lens care solution containing 0.001 to 10% by dry weight dexpanthenol is also provided.
Owner:BRIEN HOLDEN VISION INST (AU)

Contact lens care solution

The invention discloses a contact lens care solution with good sterilizing effect. The contact lens care solution is composed of the following components in percentage by weight: 0.1-2% of cellulose, 0.05-0.5% of biguanide polycyclic ethane, 0.05-1% of polyhexamethylene guanidine, 0.1-2% of boric acid, 0.01-0.2% of borax, 0.1-3% of borneol, 1-3% of ethanol, and the balance of distilled water. A preparation method of the contact lens care solution comprises the following steps of: (1) heating up biguanide polycyclic ethane and polyhexamethylene guanidine to 40 DEG C according to a proportion for dissolution; (2) dissolving borneol with ethanol, then adding borneol to a solution of the step (1); (3) adding cellulose, boric acid and borax to the above solution, heating up to 85 DEG C, fully stirring and mixing, then filling to a closed container, standing at the room temperature for 24 hours, and sterilizing for 1 hour; and (4) filling the sterilized and cooled solution to a sterile eye drop bottle.
Owner:孙立伟
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products